Wechseln Sie zum Testsieger und sichern Sie sich bis zu 4.000 € Prämie für Ihr Fondsdepot!-w-
06.12.2021 23:45

Nike (NKE) Stock Sinks As Market Gains: What You Should Know

Folgen
Werbung
Nike (NKE) closed at $168.91 in the latest trading session, marking a -0.78% move from the prior day. This move lagged the S&P 500's daily gain of 1.17%. Elsewhere, the Dow gained 1.87%, while the tech-heavy Nasdaq added 0.62%.Heading into today, shares of the athletic apparel maker had lost 4.1% over the past month, outpacing the Consumer Discretionary sector's loss of 8.83% and lagging the S&P 500's loss of 2.46% in that time.Wall Street will be looking for positivity from Nike as it approaches its next earnings report date. This is expected to be December 20, 2021. The company is expected to report EPS of $0.62, down 20.51% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $11.23 billion, down 0.09% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $3.56 per share and revenue of $47.11 billion. These totals would mark changes of 0% and +5.76%, respectively, from last year.Any recent changes to analyst estimates for Nike should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Nike is holding a Zacks Rank of #3 (Hold) right now.Looking at its valuation, Nike is holding a Forward P/E ratio of 47.76. This valuation marks a premium compared to its industry's average Forward P/E of 21.24.It is also worth noting that NKE currently has a PEG ratio of 3.28. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Shoes and Retail Apparel industry currently had an average PEG ratio of 1.11 as of yesterday's close.The Shoes and Retail Apparel industry is part of the Consumer Discretionary sector. This industry currently has a Zacks Industry Rank of 228, which puts it in the bottom 11% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.Investor Alert: Legal Marijuana Looking for big gains?Now is the time to get in on a young industry primed to skyrocket from $13.5 billion in 2021 to an expected $70.6 billion by 2028.After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could kick start an even greater bonanza for investors. Zacks Investment Research has recently closed pot stocks that have shot up as high as +147.0%.You’re invited to immediately check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIKE, Inc. (NKE): Free Stock Analysis Report To read this article on Zacks.com click here.
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Nike Inc.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Nike Inc.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
22.12.2021Nike OutperformCredit Suisse Group
22.12.2021Nike BuyJefferies & Company Inc.
21.12.2021Nike OverweightJP Morgan Chase & Co.
06.12.2021Nike BuyGoldman Sachs Group Inc.
12.10.2021Nike BuyGoldman Sachs Group Inc.
22.12.2021Nike OutperformCredit Suisse Group
22.12.2021Nike BuyJefferies & Company Inc.
21.12.2021Nike OverweightJP Morgan Chase & Co.
06.12.2021Nike BuyGoldman Sachs Group Inc.
12.10.2021Nike BuyGoldman Sachs Group Inc.
21.12.2020Nike HoldJefferies & Company Inc.
21.12.2020Nike HoldJefferies & Company Inc.
23.09.2020Nike HoldJefferies & Company Inc.
26.06.2020Nike HoldJefferies & Company Inc.
01.05.2020Nike HoldJefferies & Company Inc.
25.06.2021Nike VerkaufenDZ BANK
23.04.2021Nike VerkaufenDZ BANK
22.12.2020Nike VerkaufenDZ BANK
26.06.2020Nike VerkaufenDZ BANK
04.10.2019Nike UnderperformBNP PARIBAS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nike Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX schließt knapp unter 16.000 Punkten -- US-Handel ruht feiertagsbedingt -- GSK lehnt Milliardenangebot von Unilever ab -- Siltronic ohne Fortschritte bei Übernahme-Prüfung -- S&T im Fokus

Siemens verkauft Yunex für fast eine Milliarde Euro. Nächster Abgang bei CureVac: Technologie-Chefin geht nach 16 Jahren. Moderna erwartet Daten zu Omikron-Impfstoff im März. BASF baut Produktion für Hexamethylendiamin und Polyamid in Europa aus. BBVA wird 2021 und 2022 mehr als 7 Milliarden Euro an Aktionäre ausschütten. Covestro will grünen Wasserstoff von australischer FFI beziehen.

Umfrage

Haben Sie Verständnis für Menschen, die gegen die Corona-Politik demonstrieren?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln